- Home
- BZUN vs ACHV Comparison
BZUN vs ACHV Comparison
Compare BZUN & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZUN
- ACHV
- Stock Information
- Founded
- BZUN 2007
- ACHV N/A
- Country
- BZUN China
- ACHV Canada
- Employees
- BZUN N/A
- ACHV N/A
- Industry
- BZUN Catalog/Specialty Distribution
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BZUN Consumer Discretionary
- ACHV Health Care
- Exchange
- BZUN Nasdaq
- ACHV Nasdaq
- Market Cap
- BZUN 166.3M
- ACHV 159.0M
- IPO Year
- BZUN N/A
- ACHV N/A
- Fundamental
- Price
- BZUN $2.42
- ACHV $4.30
- Analyst Decision
- BZUN Buy
- ACHV Strong Buy
- Analyst Count
- BZUN 2
- ACHV 3
- Target Price
- BZUN $2.20
- ACHV $14.00
- AVG Volume (30 Days)
- BZUN 236.3K
- ACHV 93.6K
- Earning Date
- BZUN 08-28-2024
- ACHV 11-07-2024
- Dividend Yield
- BZUN N/A
- ACHV N/A
- EPS Growth
- BZUN N/A
- ACHV N/A
- EPS
- BZUN N/A
- ACHV N/A
- Revenue
- BZUN $1,235,027,314.00
- ACHV N/A
- Revenue This Year
- BZUN $5.22
- ACHV N/A
- Revenue Next Year
- BZUN $5.32
- ACHV N/A
- P/E Ratio
- BZUN N/A
- ACHV N/A
- Revenue Growth
- BZUN 5.56
- ACHV N/A
- 52 Week Low
- BZUN $1.90
- ACHV $3.03
- 52 Week High
- BZUN $3.55
- ACHV $5.98
- Technical
- Relative Strength Index (RSI)
- BZUN 53.79
- ACHV 43.66
- Support Level
- BZUN $2.23
- ACHV $4.23
- Resistance Level
- BZUN $2.49
- ACHV $4.33
- Average True Range (ATR)
- BZUN 0.11
- ACHV 0.16
- MACD
- BZUN 0.02
- ACHV 0.00
- Stochastic Oscillator
- BZUN 70.84
- ACHV 32.81
About BZUN Baozun Inc.
Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.